NCT00215826View on ClinicalTrials.gov

Study of Alferon® LDO (Low Dose Oral) in Normal Volunteers

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions
Severe Acute Respiratory Syndrome
Interventions
DRUG

Alferon LDO

Trial Locations (1)

Unknown

Princess Margaret Hospital, Lai Chi Kok

Sponsors
All Listed Sponsors
lead

AIM ImmunoTech Inc.

INDUSTRY